Hepatokine FGL1 drives endothelial injury and atherogenesis via integrin β1-mediated endothelial-mesenchymal transition.
- DOI
- 10.1016/j.apsb.2026.06.005
- Published
- 2026 Sep
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.06.005,
title = {Hepatokine FGL1 drives endothelial injury and atherogenesis via integrin β1-mediated endothelial-mesenchymal transition.},
author = {Zhao Y and Chen H and Yin L and Meng R and Zheng J and Zhang Y and Wang Z and Chen Y and Xu R and Liu J and Li Y and An N and Li H and Zhang Y},
year = {2026},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2026.06.005},
url = {https://doi.org/10.1016/j.apsb.2026.06.005}
}RIS
TY - JOUR TI - Hepatokine FGL1 drives endothelial injury and atherogenesis via integrin β1-mediated endothelial-mesenchymal transition. AU - Zhao Y AU - Chen H AU - Yin L AU - Meng R AU - Zheng J AU - Zhang Y AU - Wang Z AU - Chen Y AU - Xu R AU - Liu J AU - Li Y AU - An N AU - Li H AU - Zhang Y PY - 2026 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2026.06.005 UR - https://doi.org/10.1016/j.apsb.2026.06.005 ER -
APA
Y, Z., H, C., L, Y., R, M., J, Z., Y, Z., Z, W., Y, C., R, X., J, L., Y, L., N, A., H, L., & Y, Z. (2026). Hepatokine FGL1 drives endothelial injury and atherogenesis via integrin β1-mediated endothelial-mesenchymal transition.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.06.005
Source records
- pubmed · retrieved 2026-09-25T11:02:32.880Z